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Which late-stage Alzheimer’s patients
should be referred for hospice care?
■ Evidence summary
Medicare adapted the National Hospice
Organization guidelines to determine
patients’ eligibility for hospice care.1
Recent studies, however, have identified
additional prognostic criteria that may 
better predict survival of less than 6
months in select populations (TABLE). 
Medicare guidelines are used to determine eligibility
for hospice care (strength of recommendation
[SOR]: C, based on expert opinion), but they 
correlate with 6-month mortality no better than an
experienced clinician’s judgment (SOR: B, based on
1 cohort study). Recent studies, however, have 
identified additional criteria that may better predict
survival in select populations. These prognostic 
criteria include stepwise progression to Functional
Assessment Staging Scale (FAST) stage 7c (inability
to walk without assistance) (SOR: A, based on 
2 small prospective cohort studies) and criteria
derived from the Minimum Data Set (MDS) which
include: dependency for activities of daily living,
bedbound status, bowel incontinence, comorbid
conditions (specifically cancer, congestive heart 
failure, oxygen dependence, or dyspnea), medical
instability, eating <25% of meals, sleeping most of
the day, male gender, and age >83 years (SOR: B,
based on a large retrospective cohort study).
E V I D E N C E - B A S E D A N S W E R
Combination of factors helps to estimate prognosis 
for patients with late-stage Alzheimer’s
Medicare beneficiaries must have an estimated life
expectancy of less than 6 months to be eligible for
hospice in the US. Predicting the life expectancy 
of patients with Alzheimer's disease is difficult, but
those with advanced age, impaired nutritional 
status, increased functional impairment, and
comorbid conditions have shorter survival times
with greater 6-month mortality rates. These 
variables should be used in addition to the current
Medicare guidelines in discussing a patient's prog-
nosis with family members and determining when a
hospice referral is appropriate.
Physicians should identify opportunities 
to introduce hospice as an option within the 
early care continuum of an Alzheimer's patient 
and in end-of-life discussions. A sensitive 
discussion about hospice care can ease the 
suffering and confusion of patient and family 
in making this difficult decision. In my experience,
deferring discussions about hospice may deprive
patients and family of comprehensive care at
home, emotional support, spiritual resolution, 
and financial protection.
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Deferring 
discussions about
hospice may
deprive patients 
of comprehensive
care at home,
emotional support,
and financial 
protection
FAST TRACKSchonwetter and colleagues1 conduct-
ed a retrospective chart audit of 165
patients, and a subsequent prospective
cohort study of 80 patients at comparable
stages of progressive dementia who were
consecutively admitted to a community-
based hospice program. These patients had
estimated life expectancy of less than 6
months, as certified by the attending and
the hospice medical director, without use
of explicit guidelines. The survival curves
for patients who, in retrospect, did and did
not meet Medicare guidelines were similar-
ie, the Medicare guidelines were not statis-
tically better at predicting 6-month sur-
vival than the clinical impressions of the
attending and hospice medical director. 
In the 139 patients from the retrospec-
tive cohort included in the Cox regression
analysis, 108 patients died within 6 months.
Of those, 83 (77%) met Medicare criteria
and 25 (23%) did not. Of the 31 who lived
longer than 6 months, 22 (71%) met
Medicare criteria and 9 (29%) did not. In
the prospective cohort, of the 61 patients
who died within 6 months, 39 (64%) met
Medicare criteria and 22 (36%) did not; of
the 18 who lived longer than 6 months, 9
met Medicare criteria (50%) and 9 did not.1
More recent studies have looked at the
FAST, MDS, and Global Deterioration
Scale (GDS) to identify criteria for predict-
ing 6-month mortality. The FAST rating is
based on the lowest level of function on a
scale ranging from 1 (normal) to 7f (unable
to hold up head). The GDS is similar to the
FAST, and also ranges from 1 to 7. A rating
of 5 is given to people with moderately
severe cognitive decline; 6 is severe cogni-
tive decline.
Two prospective cohort studies fol-
lowed 47 and 45 patients enrolled in hos-
pice over 2 years; these studies demonstrat-
ed that patients who reach FAST stage 7c
(inability to walk without assistance) in an
stepwise fashion are likely to live less than
T A B L E
Prognostic factors and accuracy 
for 6-month survival in Alzheimer's dementia
CITATION PROGNOSTIC FACTOR PROGNOSTIC ACCURACY 
NHO1,6 (1995) (Medicare Guidelines) FAST stage 7a*; cannot Validity was comparable 
walk without assistance; incontinence; no with clinical assessment by
meaningful communication; comorbid infection, the attending
fever, pressure ulcers, or weight loss 
Luchins2 (1997) FAST stage 7c** Mean survival=3.2 mo 
Hanrahan3 (1999) FAST stage 7c† Mean survival=4.1 mo
71% died in 6 mo
Mitchell4 (2004) In nursing home residents with Cognitive 70% risk of death within
Performance Score 5 or 6 6 months
Sum of hazard ratios of 12 MDS components
≥ 12
Morrison and GDS stage 6‡ or worse, age >70, hospitalized ~ 53% died in 6 months
Siu5 (2000) with hip fracture or pneumonia
NHO, National Hospice Organization; FAST, Functional Assessment Staging Scale; GDS, Global Deterioration Scale.
*FAST stage 7a: speaks 5–-6 words per day, and still able to ambulate.
† FAST stage 7c: unable to walk without assistance; reached this stage in ordinal (stepwise) fashion; FAST stage 7b:
speech limited to single word per average day; see www.hospice.org/pdf/webdementia.pdf for details about the
FAST scale.6
‡ GDS stage 6: dependent in activities of daily living and unaware of recent events and experiences; 
forgets name of spouse or children. See www.geriatric-resources.com/html/gds.html for more details.7
Medicare 
guidelines 
correlate with 
6-month mortality
no better than 
an experienced
clinician’s 
judgment
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FAST TRACK
6 months.2,3 In 1 of the 2 studies, patients
who reached stage 7c ordinally had a mean
survival time of 4.1 months; 71% died
within 6 months of enrollment. For the
large subset of patients who met 7c but not
in an ordinal fashion (ie, they met criteria
for 7c, but perhaps not 7a or 7b), only
30% died within 6 months, with median
survival time 10.7 months. 
Use of antibiotics did not make a sta-
tistically significant difference in survival,
and use of Foley catheters was associated
with shorter survival times (3.6 months vs
9 months; P<.03.)3 In the other study,
however, less aggressive care plans resulted
in shorter survival times (P<.01).2
In a retrospective cohort study of
11,430 nursing home residents with
advanced dementia (defined as a score of 5
or 6 on the Cognitive Performance Score,
which is itself based on MDS data, a prog-
nostic summary score was developed using
12 variables from the MDS, a federally
mandated assessment completed by nurs-
ing home staff at the time of admission.4 A
high score predicted 6-month mortality
more accurately than using an MDS corre-
late of FAST stage 7c. In the derivation
cohort (n=6799), 28.3% (n=1922) died
within 6 months; in the validation cohort
(n=4631), 35.1% (n=1626) died within 6
months. The FAST 7c correlate was found
to have a positive predictive value of only
38.5% and a sensitivity of 22% in predict-
ing death within 6 months in this popula-
tion. In contrast, using the MDS variables,
a higher threshold for the prognostic sum-
mary score resulted in a positive predictive
value of 80%, negative predictive value of
73%, specificity of 99%, but sensitivity of
only 6%. A lower cutoff yielded better sen-
sitivity (23%), and still had good specifici-
ty (96%) and negative predictive value
(76%), though the positive predictive
value was slightly lower (67%). 
Morrison and Siu conducted a
prospective cohort study of consecutive
patients admitted with hip fracture or
pneumonia to a single New York hospital
over an 18-month period.5 Survival rates of
118 advanced dementia patients, defined
by a GDS score of 6 or 7, were compared
with survival rates of 98 patients without
dementia. At 6 months, 42 (53%) of 80
pneumonia patients with end-stage demen-
tia had died, compared with 5 (13%) of 39
cognitively intact patients with pneumonia
(adjusted hazard ratio=4.6 [95% CI,
1.8–11.8]). At 6 months, 21 (55%) of 38
hip fracture patients with end-stage demen-
tia had died, compared with 7 (12%) of 59
cognitively intact patients with hip fracture
(adjusted hazard ratio=5.8 [95% CI,
1.7–20.4]). Of note, the end-stage dementia
patients with hip fracture or pneumonia
were 6 and 4 years older, respectively, than
cognitively intact patients. In addition, the
dementia patients were more likely to
reside in nursing homes (82% vs 5% with
hip fracture, 63% vs 5% with pneumonia).
A palliative care plan was not identified for
any of these patients during the admission. 
Recommendations from others
Guidelines for Medicare reimbursement for
hospice care of demented patients is out-
lined in the see first row of the TABLE.6 
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